IP
40
4
SNA
60
5
MRK
55
2
NEE
62
2
KEY
53
2
WEC
48
2
WU
52
10
TROW
58
2
SWKS
42
5
EMC
89
15
SRE
54
2
HON
58
4
T
44
2
FTI
86
2
MNST
65
5
APH
73
2
PNR
63
3
HCA
50
2
WDC
58
4
AAPL
70
9
IP
40
4
SNA
60
5
MRK
55
2
NEE
62
2
KEY
53
2
WEC
48
2
WU
52
10
TROW
58
2
SWKS
42
5
EMC
89
15
SRE
54
2
HON
58
4
T
44
2
FTI
86
2
MNST
65
5
APH
73
2
PNR
63
3
HCA
50
2
WDC
58
4
AAPL
70
9
Financhill
Back

Perspective Therapeutics Quote, Financials, Valuation and Earnings

Will Crypto Make People Rich Again Starting April 2024?

Details on how to profit here.
Buy
84

CATX
Perspective Therapeutics

Last Price:
1.81
Seasonality Move:
3.58%

7 Day Trial

ALL ACCESS PASS

$ 7

The little-known AI stock you need to read about now...

Get the name - FREE.

Perspective Therapeutics Price Quote

$1.81

Perspective Therapeutics Key Stats

Buy
84
Perspective Therapeutics (CATX) is a Buy
Day range:
$1.72 - $1.87
52-week range:
$0.21 - $1.87
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
14.13%
Volume:
4.7M
Avg. volume:
5.6M
1-year change:
195.99%
Market cap:
$1.1B
Revenue:
$0
EPS:
$-0.17

How Much Does Perspective Therapeutics Make?

Data Unavailable

Is Perspective Therapeutics Growing As A Company?

Data Unavailable

Perspective Therapeutics Stock Price Performance

What Is Perspective Therapeutics 52-Week High & Low?

Perspective Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Perspective Therapeutics?

Is Perspective Therapeutics Cash Flow Positive?

  • What Is CATX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$36.9M
  • What Is Perspective Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $785K
  • What Is Perspective Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $24.4M

Perspective Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    CATX return on invested capital is -49.97%
  • What Is Perspective Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -44.83%
  • What Is CATX Return On Equity?
    ROE is a measure of profitability and is -50.74%

Perspective Therapeutics Earnings Date & Stock Price

Perspective Therapeutics Competitors

Perspective Therapeutics Dividend Yield

Data Unavailable

Perspective Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% -331.06%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 1.57
Downside from Last Price: -13.44%

Major Shareholders

  • How many CATX shares are owned by institutional investors?
    96.5M CATX shares are owned by institutional investors
  • How many CATX shares are owned by insiders?
    4.4M CATX shares are owned by insiders